Henry Schein (HSIC) Tops Q2 EPS by 1c, Beats on Revenues; Offers FY17 EPS Guide Midpoint Below Consensus

Henry Schein (NASDAQ: HSIC) reported Q2 EPS of $1.75, $0.01 better than the analyst estimate of $1.74. Revenue for the quarter came in at $3.06 billion versus the consensus estimate of $3.05 billion.

2017 EPS Guidance

Henry Schein expects full year 2017 diluted EPS to be in the same range as previously disclosed, except for the $0.04 litigation settlement expense.

• 2017 GAAP diluted EPS attributable to Henry Schein, Inc., which includes the litigation settlement expense of $0.04 per diluted share, is expected to be $7.13 to $7.26. This guidance reflects growth of 15% to 17% compared with 2016 GAAP diluted EPS of $6.19. The prior GAAP diluted EPS guidance range was $7.17 to $7.30.
• 2017 non-GAAP diluted EPS, which excludes the litigation settlement expense of $0.04 per diluted share, is expected to be $7.17 to $7.30. This guidance reflects growth of 8% to 10% compared with 2016 non-GAAP diluted EPS of $6.61. Note that full year 2016 non-GAAP diluted EPS excludes restructuring charges of $0.42 per diluted share.
• The Company notes that fiscal year 2017 includes one less week than fiscal year 2016.
• Guidance for 2017 GAAP and non-GAAP diluted EPS is for current continuing operations as well as completed or previously announced acquisitions, and does not include the impact of potential future acquisitions, if any. Guidance also assumes foreign exchange rates that are generally consistent with current levels.

GUIDANCE:

Henry Schein sees FY2017 EPS of $7.17-$7.30, versus the consensus of $7.29.

For earnings history and earnings-related data on Henry Schein (HSIC) click here.

You May Also Be Interested In

• Freeport-McMoran (FCX) Commences Commissioning of New Indonesian Smelter and Provides Update on Second-Quarter 2024 Copper and Gold Sales
• Forward Air (FWRD) PT Raised to $17 at Baird
• Quest Diagnostics (DGX) to Acquire LifeLabs from OMERS